TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 NOK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
338,898
|
331,297
|
430,479 |
| Financial expenses |
955
|
934
|
1,398 |
| Earnings before taxes |
13,246
|
26,304
|
7,773 |
| EBITDA |
13,397
|
26,307
|
9,427 |
| Total assets |
349,899
|
379,310
|
246,431 |
| Current assets |
349,898
|
379,220
|
246,161 |
| Current liabilities |
146,543
|
196,505
|
86,301 |
| Equity capital |
81,253
|
67,431
|
46,229 |
| - share capital |
212
|
201
|
198 |
| Employees (average) |
34
|
38
|
46 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
23.2%
|
17.8%
|
18.8% |
| Turnover per employee |
9,968
|
8,718
|
9,358 |
| Profit as a percentage of turnover |
3.9%
|
7.9%
|
1.8% |
| Return on assets (ROA) |
4.1%
|
7.2%
|
3.7% |
| Current ratio |
238.8%
|
193.0%
|
285.2% |
| Return on equity (ROE) |
16.3%
|
39.0%
|
16.8% |
| Change turnover |
-11,720
|
-104,752
|
188,920 |
| Change turnover % |
-3%
|
-24%
|
78% |
| Chg. No. of employees |
-4
|
-8
|
6 |
| Chg. No. of employees % |
-11%
|
-17%
|
15% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.